Skip to main content

Monaco Asset Management SAM

SEC CIK
0001803593
Latest filing
Aug 7, 2026

IOVA holding history

Iovance Biotherapeutics, Inc. in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IOVA overviewAll 13F holders of IOVAFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2022
Holdings of IOVA by Monaco Asset Management SAM, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−225,000−100.0%Sold outHolders
Q1 2026225,000$789.8K0.3%+225,000NewHolders
Q1 20230$00.0%−115,000−100.0%Sold outHolders
Q4 2022115,000$734.9K0.3%+115,000NewHolders